Silkim Pharma has developed a novel, protected platform of drugs for proven treatments of multiple indications. The company's platform is the result of extensive investigation of animal models of human diseases. Members of the platform act as potent anti-inflammatory agents, strong iron-chelating agents, and antibiotic agents. These modes of action jointly assist in treating the causes and/or symptoms of multiple indications.
Cumulative Funding Raised Over Time ($)
Employees Over Time
Silkim Pharma Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
May 24, 2020
jlm-biocity.org
Silkim Pharma's New Drug Against Coronavirus Receives Response from FDA in Record Time!! - JLM-BioCity